Paper17525342
Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response.
Kim H and 2 others. Science, 2007. Cited by 467 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Papers, record 17525342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17525342
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| BRCA1 Protein | Major topic |
| Carrier Proteins | Major topic |
| DNA | Major topic |
| DNA Damage | Major topic |
| DNA Repair | Major topic |
| Nuclear Proteins | Major topic |
| Ubiquitin | Major topic |
| Amino Acid Sequence | |
| Cell Cycle | |
| Cell Line, Tumor | |
| DNA-Binding Proteins | |
| HeLa Cells | |
| Histone Chaperones | |
| Humans | |
| Molecular Sequence Data | |
| Protein Binding | |
| Protein Structure, Tertiary | |
| RNA, Small Interfering | |
| Radiation, Ionizing |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01CA089239 | NCI NIH HHS | United States | R01CA089239 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 17525326 | Cell signaling. A touching response to damage. | https://conductscience.org/library/papers/17525326 |
Source PubMed
Cited by345
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 467 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42760358 | Mechanisms and disease relevance of DNA break repair pathway choice. | Nat Rev Mol Cell Biol | 2026 | https://conductscience.org/library/papers/42760358 | PubMed |
| 42581301 | Mechanism of K63-linked polyubiquitin recognition and cleavage by the BRCA1-A complex. | Nat Commun | 2026 | https://conductscience.org/library/papers/42581301 | PubMed |
| 42581048 | A ubiquitin chain-feeding mechanism for BRCA1-A. | Nat Commun | 2026 | https://conductscience.org/library/papers/42581048 | PubMed |
| 42511095 | Whole-Genome Resequencing-Based Selection-Signal and Association Analyses Prioritize Candidate Genes and Haplotypes for PRRS Resistance-Related Traits in Pigs. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42511095 | PubMed |
| 42406631 | CDW19S coordinates phasic end processing via distinct enzymatic activities. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42406631 | PubMed |
| 42401588 | The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells. | Nat Commun | 2026 | https://conductscience.org/library/papers/42401588 | PubMed |
| 41889868 | The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells. | bioRxiv | 2026 | https://conductscience.org/library/papers/41889868 | PubMed |
| 41555391 | The mutual regulation of SOX12 and RNF168 modulates cisplatin resistance in esophageal squamous cell carcinoma cells by regulating DNA damage repair. | Cell Biosci | 2026 | https://conductscience.org/library/papers/41555391 | PubMed |
| 41359628 | The deubiquitinating enzyme Cezanne stabilizes BRCA1 by counteracting APC/C and Ube2S-dependent Lys11-linked ubiquitination. | PLoS Biol | 2025 | https://conductscience.org/library/papers/41359628 | PubMed |
| 41071892 | Targeting the ATM-TRMT10A-BRCA1 axis confers synthetic lethality to PARP inhibition in metastatic castration-resistant prostate cancer. | Sci Adv | 2025 | https://conductscience.org/library/papers/41071892 | PubMed |
| 41006228 | EXO1 as a therapeutic target for Fanconi Anaemia, ZRSR2 and BRCA1-A complex deficient cancers. | Nat Commun | 2025 | https://conductscience.org/library/papers/41006228 | PubMed |
| 40523654 | Complex Interplay Between Obesity and BRCA1/2-Associated Breast Cancer: An Overview. | Obes Rev | 2025 | https://conductscience.org/library/papers/40523654 | PubMed |
| 40496644 | Rare SNP in the HELB gene interferes with RPA interaction and cellular function of HELB. | NAR Mol Med | 2025 | https://conductscience.org/library/papers/40496644 | PubMed |
| 40419791 | Post-translational modifications in DNA damage repair: mechanisms underlying temozolomide resistance in glioblastoma. | Oncogene | 2025 | https://conductscience.org/library/papers/40419791 | PubMed |
| 40240356 | USP28 promotes PARP inhibitor resistance by enhancing SOX9-mediated DNA damage repair in ovarian cancer. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40240356 | PubMed |
| 40097626 | Molecular glues that inhibit deubiquitylase activity and inflammatory signaling. | Nat Struct Mol Biol | 2025 | https://conductscience.org/library/papers/40097626 | PubMed |
| 39588777 | STK39-mediated amplification of γ-H2A.X promotes homologous recombination and contributes to PARP inhibitor resistance. | Nucleic Acids Res | 2024 | https://conductscience.org/library/papers/39588777 | PubMed |
| 39510841 | BRCA1 and BRCA2: from cancer susceptibility to synthetic lethality. | Genes Dev | 2025 | https://conductscience.org/library/papers/39510841 | PubMed |
| 39389815 | DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1. | Trends Pharmacol Sci | 2024 | https://conductscience.org/library/papers/39389815 | PubMed |
| 39315145 | Identification of ubiquitin markers for survival and prognosis of ovarian cancer. | Heliyon | 2024 | https://conductscience.org/library/papers/39315145 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| UIMC1 | 51720 | Swiss-Prot's references | https://conductscience.org/library/genes/51720 | NCBI Gene |
| BARD1 | 580 | PubTator's text mining | https://conductscience.org/library/genes/580 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRIP1 | 83990 | PubTator's text mining | https://conductscience.org/library/genes/83990 | NCBI Gene |
| RBBP8 | 5932 | PubTator's text mining | https://conductscience.org/library/genes/5932 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17525342
GET https://conductscience.org/api/papers/v1/17525342/cited_by?page=2